Co-Authors
This is a "connection" page, showing publications co-authored by George Gao and Jinghua Yan.
Connection Strength
4.071
-
Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nat Commun. 2021 Apr 15; 12(1):2355.
Score: 0.235
-
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 08; 21(8):1107-1119.
Score: 0.234
-
A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nat Commun. 2021 02 03; 12(1):776.
Score: 0.232
-
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell. 2020 08 06; 182(3):722-733.e11.
Score: 0.222
-
Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex. Cell Mol Immunol. 2020 09; 17(9):966-975.
Score: 0.208
-
Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus. Nat Microbiol. 2019 07; 4(7):1231-1241.
Score: 0.204
-
Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab. Cell Rep. 2018 10 23; 25(4):909-920.e4.
Score: 0.198
-
Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage. J Virol. 2018 03 15; 92(6).
Score: 0.189
-
CASCIRE surveillance network and work on avian influenza viruses. Sci China Life Sci. 2017 12; 60(12):1386-1391.
Score: 0.186
-
CTL immunogenicity of Rv3615c antigen and diagnostic performances of an ESAT-6/CFP-10/Rv3615c antigen cocktail for Mycobacterium tuberculosis infection. Tuberculosis (Edinb). 2017 12; 107:5-12.
Score: 0.182
-
Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies. Oncotarget. 2017 Sep 15; 8(40):67129-67139.
Score: 0.179
-
Structural basis of nectin-1 recognition by pseudorabies virus glycoprotein D. PLoS Pathog. 2017 May; 13(5):e1006314.
Score: 0.179
-
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017 04 10; 8:15092.
Score: 0.178
-
An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun. 2017 02 06; 8:14369.
Score: 0.176
-
Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs. Biochemistry. 2016 Nov 01; 55(43):5977-5988.
Score: 0.172
-
MERS-CoV spike protein: Targets for vaccines and therapeutics. Antiviral Res. 2016 09; 133:165-77.
Score: 0.169
-
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015 Nov; 25(11):1237-49.
Score: 0.160
-
Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 2014 Sep 10; 16(3):328-37.
Score: 0.149
-
Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol. 2013 Dec; 87(24):13134-40.
Score: 0.139
-
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013 Aug 08; 500(7461):227-31.
Score: 0.137
-
The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis. 2010 Oct 15; 202(8):1171-80.
Score: 0.114
-
SARS-CoV nucleocapsid protein binds to hUbc9, a ubiquitin conjugating enzyme of the sumoylation system. J Med Virol. 2006 Nov; 78(11):1365-73.
Score: 0.086
-
Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study. BMC Infect Dis. 2018 Dec 14; 18(1):664.
Score: 0.050
-
Endogenous Cellular MicroRNAs Mediate Antiviral Defense against Influenza A Virus. Mol Ther Nucleic Acids. 2018 Mar 02; 10:361-375.
Score: 0.047
-
Hemagglutinin-specific CD4+ T-cell responses following 2009-pH1N1 inactivated split-vaccine inoculation in humans. Vaccine. 2017 10 09; 35(42):5644-5652.
Score: 0.046